{"entity":{"type":"insider","cik":"0001500210","url":"/insider/0001500210","json_url":"/insider/0001500210.json","name":"Bailey Jeffrey Allen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2019-11-14","last":"2024-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Bailey Jeffrey Allen","source":"filing","n_filings":8,"first_seen":"2019-11-14","last_seen":"2024-11-12"}],"transactions":[{"id":2063422,"accession":"0001600620-24-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001600620-24-000116","line_url":"/filing/0001600620-24-000116#line-2","is_derivative":false,"issuer_cik":"0001500210","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001500210","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4557.0,"shares_display":"4,557","price_per_share":8.43,"price_display":"8.43","price_state":"stated","total_value":38415.51,"total_display":"38,415.51","total_whole":"38,416","shares_owned_after":13356.0,"shares_owned_after_display":"13,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-12","scope":"insider"},{"id":2333405,"accession":"0001103021-20-000158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-20-000158","line_url":"/filing/0001103021-20-000158#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.35,"price_display":"4.35","price_state":"stated","total_value":43500.0,"total_display":"43,500.00","total_whole":"43,500","shares_owned_after":35567.0,"shares_owned_after_display":"35,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":3176849,"accession":"0001104659-20-107790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-107790","line_url":"/filing/0001104659-20-107790#line-1","is_derivative":false,"issuer_cik":"0000805267","issuer_name":"TEKLA HEALTHCARE INVESTORS","issuer_ticker":"HQH","issuer_name_source":null,"issuer_url":"/issuer/0000805267","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Shares of Beneficial Interest","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":490.0,"shares_display":"490","price_per_share":20.39,"price_display":"20.39","price_state":"stated","total_value":9991.1,"total_display":"9,991.10","total_whole":"9,991","shares_owned_after":490.0,"shares_owned_after_display":"490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":2806868,"accession":"0001104659-20-107792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-107792","line_url":"/filing/0001104659-20-107792#line-1","is_derivative":false,"issuer_cik":"0001500210","issuer_name":"Tekla World Healthcare Fund","issuer_ticker":"THW","issuer_name_source":null,"issuer_url":"/issuer/0001500210","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Shares of Beneficial Interest","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":710.0,"shares_display":"710","price_per_share":14.18,"price_display":"14.18","price_state":"stated","total_value":10067.8,"total_display":"10,067.80","total_whole":"10,068","shares_owned_after":710.0,"shares_owned_after_display":"710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":2142605,"accession":"0001104659-20-107791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-107791","line_url":"/filing/0001104659-20-107791#line-1","is_derivative":false,"issuer_cik":"0001500210","issuer_name":"Tekla Healthcare Opportunities Fund","issuer_ticker":"THQ","issuer_name_source":null,"issuer_url":"/issuer/0001500210","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Shares of Beneficial Interest","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":570.0,"shares_display":"570","price_per_share":17.68,"price_display":"17.68","price_state":"stated","total_value":10077.6,"total_display":"10,077.60","total_whole":"10,078","shares_owned_after":570.0,"shares_owned_after_display":"570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":2424925,"accession":"0001104659-20-107789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-107789","line_url":"/filing/0001104659-20-107789#line-1","is_derivative":false,"issuer_cik":"0000884121","issuer_name":"TEKLA LIFE SCIENCES INVESTORS","issuer_ticker":"HQL","issuer_name_source":null,"issuer_url":"/issuer/0000884121","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Shares of Beneficial Interest","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":580.0,"shares_display":"580","price_per_share":17.28,"price_display":"17.28","price_state":"stated","total_value":10022.4,"total_display":"10,022.40","total_whole":"10,022","shares_owned_after":580.0,"shares_owned_after_display":"580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-22","filed_date":"2020-09-23","scope":"insider"},{"id":8761991,"accession":"0000899243-19-027510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027510","line_url":"/filing/0000899243-19-027510#line-2","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39142.0,"shares_display":"39,142","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":19962.42,"total_display":"19,962.42","total_whole":"19,962","shares_owned_after":74894.0,"shares_owned_after_display":"74,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-18","scope":"insider"},{"id":8761988,"accession":"0000899243-19-027510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027510","line_url":"/filing/0000899243-19-027510#line-1","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15858.0,"shares_display":"15,858","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":8087.58,"total_display":"8,087.58","total_whole":"8,088","shares_owned_after":35752.0,"shares_owned_after_display":"35,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"},{"id":8197992,"accession":"0000899243-19-027279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027279","line_url":"/filing/0000899243-19-027279#line-1","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001500210","owner_name":"Bailey Jeffrey Allen","owner_display_name":"Bailey Jeffrey Allen","owner_url":"/insider/0001500210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19894.0,"shares_display":"19,894","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":10543.82,"total_display":"10,543.82","total_whole":"10,544","shares_owned_after":19894.0,"shares_owned_after_display":"19,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Director","n_filings":1,"first_seen":"2024-11-12","last_seen":"2024-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001103021","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","url":"/issuer/0001103021","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2020-12-16","last_seen":"2020-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000805267","name":"TEKLA HEALTHCARE INVESTORS","url":"/issuer/0000805267","role":"Director","n_filings":1,"first_seen":"2020-09-23","last_seen":"2020-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000884121","name":"TEKLA LIFE SCIENCES INVESTORS","url":"/issuer/0000884121","role":"Director","n_filings":1,"first_seen":"2020-09-23","last_seen":"2020-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001604522","name":"Tekla Healthcare Opportunities Fund","url":"/issuer/0001604522","role":"Director","n_filings":1,"first_seen":"2020-09-23","last_seen":"2020-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001635977","name":"Tekla World Healthcare Fund","url":"/issuer/0001635977","role":"Director","n_filings":1,"first_seen":"2020-09-23","last_seen":"2020-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"AILERON THERAPEUTICS INC","url":"/issuer/0001420565","role":"Director","n_filings":2,"first_seen":"2019-11-14","last_seen":"2019-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001500210","retrieved_at":"2026-08-27T02:09:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}